SCHEMBL4394020

SCHEMBL4394020

CCc1c(O)cc(O)c(-c2ccccc2)c1CCC(C(=O)OC)C(=O)OC

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 1/20 0.40
SMN1; SMN2 Q16637 3/20 0.37
KMT2A Q03164 3/20 0.37
POLB P06746 3/20 0.37
RECQL P46063 1/20 0.37
GAA P10253 3/20 0.36
ESR1 P03372 2/20 0.36
ESR2 Q92731 2/20 0.36
KDM4E B2RXH2 1/20 0.36
NPC1 O15118 1/20 0.36
ALDH1A1 P00352 1/20 0.36
LMNA P02545 1/20 0.36
MAPT P10636 1/20 0.36
HPGD P15428 1/20 0.36
RAB9A P51151 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
ADORA3 P0DMS8 3/20 0.35
PDE4B Q07343 2/20 0.35
PDE4A P27815 1/20 0.35
PDE4C Q08493 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4380942 0.78 L3MBTL1 (0.43) CNR2SMN1; SMN2POLBRECQLGAA
SCHEMBL4386612 0.78 ESR1 (0.40) CNR2SMN1; SMN2POLBRECQLESR1
SCHEMBL4387542 0.78 ESR1 (0.41) CNR2SMN1; SMN2POLBRECQLESR1
SCHEMBL4386191 0.77 POLB (0.42) CNR2SMN1; SMN2POLBRECQLESR1
SCHEMBL4386201 0.76 ESR1 (0.38) CNR2SMN1; SMN2POLBRECQLESR1
SCHEMBL4387388 0.76 ESR1 (0.44) CNR2SMN1; SMN2POLBRECQLESR1
SCHEMBL4387537 0.75 ESR1 (0.37) CNR2SMN1; SMN2POLBRECQLESR1
SCHEMBL4381518 0.75 GCGR (0.39) CNR2SMN1; SMN2POLBRECQLESR1
SCHEMBL4389478 0.74 CNR2 (0.39) CNR2SMN1; SMN2KMT2APOLBRECQL
SCHEMBL4386231 0.73 ESR1 (0.38) CNR2SMN1; SMN2POLBRECQLESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7538241-B2 Hsp90 family protein inhibitors KYOWA HAKKO KOGYO CO., LTD. (JP) 2009-05-26 US disclosed
US-20070155813-A1 Hsp90 family protein inhibitors KYOWA HAKKO KOGYO CO., LTD. (JP) 2007-07-05 US disclosed
EP-1704856-A1 HSP90 FAMILY PROTEIN INHIBITOR KYOWA HAKKO KOGYO CO., LTD. (JP) 2006-09-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070155813-A1 Hsp90 family protein inhibitors HSP90AB1, HEATR1, HSP90AB2P CNR2 1898/4885SMN1; SMN2 4471/4885KMT2A 3994/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.